The role of Smad signaling cascades in cardiac fibrosis.

[1]  N. Frangogiannis,et al.  Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of non-reperfused myocardial infarction. , 2020, American journal of physiology. Heart and circulatory physiology.

[2]  S. Nagueh.  Heart Failure with Preserved Ejection Fraction: Insights into Diagnosis and Pathophysiology. , 2020, Cardiovascular research.

[3]  B. Hinz,et al.  The myofibroblast at a glance , 2020, Journal of Cell Science.

[4]  M. Czubryt,et al.  Targeting the Renin-Angiotensin-Aldosterone System in Fibrosis. , 2020, Matrix biology : journal of the International Society for Matrix Biology.

[5]  D. Tilley,et al.  Leukocyte-Dependent Regulation of Cardiac Fibrosis , 2020, Frontiers in Physiology.

[6]  T. Newsome,et al.  Cell‐to‐cell spread of vaccinia virus is promoted by TGF‐β‐independent Smad4 signalling , 2020, Cellular microbiology.

[7]  N. Frangogiannis,et al.  The role of Smad2 and Smad3 in regulating homeostatic functions of fibroblasts in vitro and in adult mice. , 2020, Biochimica et biophysica acta. Molecular cell research.

[8]  Joseph A. Hill,et al.  Role of FoxO3a as a negative regulator of the cardiac myofibroblast conversion induced by TGF-β1. , 2020, Biochimica et biophysica acta. Molecular cell research.

[9]  Daniel A. Skelly,et al.  Dynamic Interstitial Cell Response during Myocardial Infarction Predicts Resilience to Rupture in Genetically Diverse Mice , 2020, Cell reports.

[10]  N. Frangogiannis.  Transforming growth factor–β in tissue fibrosis , 2020, The Journal of experimental medicine.

[11]  B. Hinz,et al.  TGF-β1 - A truly transforming growth factor in fibrosis and immunity. , 2019, Seminars in cell & developmental biology.

[12]  Daniel A. Skelly,et al.  High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy , 2019, bioRxiv.

[13]  L. Hsiao,et al.  The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human. , 2019, Journal of molecular and cellular cardiology.

[14]  N. Frangogiannis,et al.  The Role of the TGF-β Superfamily in Myocardial Infarction , 2019, Front. Cardiovasc. Med..

[15]  Qiuyun Chen,et al.  ADAMTS16 Activates Latent TGF-beta, Accentuating Fibrosis and Dysfunction of the Pressure-overloaded Heart. , 2019, Cardiovascular research.

[16]  N. Frangogiannis,et al.  Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart. , 2019, Journal of molecular and cellular cardiology.

[17]  W. Degrave,et al.  TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease , 2019, PLoS neglected tropical diseases.

[18]  J. Graff,et al.  Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation. , 2019, Circulation research.

[19]  N. Frangogiannis,et al.  Fibroblasts in the Infarcted, Remodeling, and Failing Heart , 2019, JACC. Basic to translational science.

[20]  Kristin M. French,et al.  Fibroblast Primary Cilia Are Required for Cardiac Fibrosis. , 2019, Circulation.

[21]  J. Graff,et al.  Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program , 2019, Circulation research.

[22]  Richard P Harvey,et al.  Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury , 2019, eLife.

[23]  Ryan M Burke,et al.  Pre-existing fibroblasts of epicardial origin are the primary source of pathological fibrosis in cardiac ischemia and aging. , 2019, Journal of molecular and cellular cardiology.

[24]  Liming Chen,et al.  SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart , 2019, Cardiovascular Diabetology.

[25]  N. Frangogiannis.  Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. , 2019, Molecular aspects of medicine.

[26]  T. Force,et al.  Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis , 2019, JACC. Basic to translational science.

[27]  T. Dominko,et al.  Crosstalk between mitogen-activated protein kinase inhibitors and transforming growth factor-β signaling results in variable activation of human dermal fibroblasts , 2018, International journal of molecular medicine.

[28]  M. Caligiuri,et al.  SMAD4 promotes TGF-&bgr;–independent NK cell homeostasis and maturation and antitumor immunity , 2018, The Journal of clinical investigation.

[29]  H. Zhang,et al.  Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts , 2018, Journal of the American Heart Association.

[30]  N. Frangogiannis,et al.  Aging, cardiac repair and Smad3 , 2018, Aging.

[31]  R. Kim,et al.  Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse. , 2018, Journal of the American College of Cardiology.

[32]  D. Kitzman,et al.  Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2. , 2018, JACC. Heart failure.

[33]  B. Hinz,et al.  The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix , 2018, Journal of Cell Science.

[34]  J. Graff,et al.  Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium , 2017, Circulation.

[35]  M. Aronovitz,et al.  Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure , 2017, The Journal of experimental medicine.

[36]  J. Molkentin,et al.  Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. , 2017, The Journal of clinical investigation.

[37]  Daniel C. Lee,et al.  Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-&bgr; and Cardiac Fibrosis , 2017, Circulation.

[38]  G. Melino,et al.  Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling , 2017, Cardiovascular research.

[39]  K. Flanders,et al.  Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[40]  K. Hahm,et al.  Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts , 2017, BMC Gastroenterology.

[41]  K. Miyazono,et al.  Regulation of TGF-β Family Signaling by Inhibitory Smads. , 2017, Cold Spring Harbor perspectives in biology.

[42]  Danping Liu,et al.  Bone Morphogenetic Protein-7 Antagonizes Myocardial Fibrosis Induced by Atrial Fibrillation by Restraining Transforming Growth Factor-β (TGF-β)/Smads Signaling , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[43]  A. Hata,et al.  TGF-β Signaling from Receptors to Smads. , 2016, Cold Spring Harbor perspectives in biology.

[44]  C. Heldin,et al.  Signaling Receptors for TGF-β Family Members. , 2016, Cold Spring Harbor perspectives in biology.

[45]  B. Aronow,et al.  Genetic lineage tracing defines myofibroblast origin and function in the injured heart , 2016, Nature Communications.

[46]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[47]  D. Harrison,et al.  BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction. , 2016, Circulation research.

[48]  F. Recchia,et al.  Follistatin‐like 1 promotes cardiac fibroblast activation and protects the heart from rupture , 2016, EMBO molecular medicine.

[49]  U. Eriksson,et al.  Transforming growth factor-&bgr;-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis , 2016, European heart journal.

[50]  D. Mann,et al.  Role of inflammatory cells in fibroblast activation. , 2016, Journal of molecular and cellular cardiology.

[51]  J. Sowers,et al.  Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females , 2015, Hypertension.

[52]  G. Blobe,et al.  TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling , 2015, Molecular biology of the cell.

[53]  Xiao-Fan Wang,et al.  Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice , 2015, Circulation. Heart failure.

[54]  R. Karas,et al.  Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure , 2015, Circulation. Heart failure.

[55]  K. Jishage,et al.  Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy , 2015, Diabetes.

[56]  W. Edwards,et al.  Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction , 2015, Circulation.

[57]  N. Frangogiannis.  Targeting the transforming growth factor (TGF)-β cascade in the remodeling heart: benefits and perils. , 2014, Journal of molecular and cellular cardiology.

[58]  I. Sjaastad,et al.  Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5. , 2014, Journal of molecular and cellular cardiology.

[59]  K. Sharma.  Obesity, oxidative stress, and fibrosis in chronic kidney disease , 2014, Kidney international supplements.

[60]  N. Frangogiannis,et al.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. , 2014, Translational research : the journal of laboratory and clinical medicine.

[61]  D. Kaye,et al.  Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury. , 2014, Cytokine.

[62]  K. Red-Horse,et al.  Developmental Heterogeneity of Cardiac Fibroblasts Does Not Predict Pathological Proliferation and Activation , 2014, Circulation research.

[63]  D. Brenner,et al.  Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.

[64]  B. Hinz,et al.  Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction. , 2014, Cardiovascular research.

[65]  N. Frangogiannis,et al.  The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.

[66]  N. Frangogiannis,et al.  Fibroblasts in myocardial infarction: a role in inflammation and repair. , 2014, Journal of molecular and cellular cardiology.

[67]  W. Seeger,et al.  Glucocorticoids Recruit Tgfbr3 and Smad1 to Shift Transforming Growth Factor-β Signaling from the Tgfbr1/Smad2/3 Axis to the Acvrl1/Smad1 Axis in Lung Fibroblasts* , 2013, The Journal of Biological Chemistry.

[68]  N. Frangogiannis,et al.  Thrombospondin-1 Induction in the Diabetic Myocardium Stabilizes the Cardiac Matrix in Addition to Promoting Vascular Rarefaction Through Angiopoietin-2 Upregulation , 2013, Circulation research.

[69]  B. Yan,et al.  Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. , 2013, Cardiovascular research.

[70]  B. Yan,et al.  Deficiency of Smad7 Enhances Cardiac Remodeling Induced by Angiotensin II Infusion in a Mouse Model of Hypertension , 2013, PloS one.

[71]  H. Schaff,et al.  TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. , 2013, Cardiovascular research.

[72]  G. Díaz-Araya,et al.  TGF-β1 prevents simulated ischemia/reperfusion-induced cardiac fibroblast apoptosis by activation of both canonical and non-canonical signaling pathways. , 2013, Biochimica et biophysica acta.

[73]  M. Hurlé,et al.  BAMBI (BMP and activin membrane-bound inhibitor) protects the murine heart from pressure-overload biomechanical stress by restraining TGF-β signaling. , 2013, Biochimica et biophysica acta.

[74]  K. Connelly,et al.  α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy. , 2012, Cardiovascular research.

[75]  M. Czubryt,et al.  Synergistic roles of scleraxis and Smads in the regulation of collagen 1α2 gene expression. , 2012, Biochimica et biophysica acta.

[76]  Mansher Singh,et al.  Modulation of Transforming Growth Factor-&bgr; Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers , 2012, Circulation.

[77]  J. Doré,et al.  TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling , 2012, PloS one.

[78]  A. Dart,et al.  Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions. , 2012, Pharmacology & therapeutics.

[79]  Hui Li,et al.  Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression. , 2012, Gene.

[80]  B. Coller,et al.  Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. , 2012, Blood.

[81]  Li-Ling Wu,et al.  Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. , 2011, Cardiovascular research.

[82]  J. Gardner,et al.  Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. , 2011, Cytokine.

[83]  J. Ge,et al.  Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. , 2011, European journal of pharmacology.

[84]  S. Butz,et al.  GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice , 2011, Nature Medicine.

[85]  A. Hatzopoulos,et al.  Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition , 2011, Disease Models & Mechanisms.

[86]  N. Frangogiannis,et al.  Aging and Cardiac Fibrosis. , 2011, Aging and disease.

[87]  Shenming Wang,et al.  Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7 , 2011, Circulation research.

[88]  Xiao-Fan Wang,et al.  Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction , 2010, Circulation research.

[89]  Hiroshi Yamamoto,et al.  Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy , 2010, Diabetes.

[90]  K. Miyazono,et al.  Smad7 Inhibits Transforming Growth Factor-β Family Type I Receptors through Two Distinct Modes of Interaction* , 2010, The Journal of Biological Chemistry.

[91]  K. Hirata,et al.  Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition , 2010, Circulation.

[92]  C. Lau,et al.  Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling , 2010, Hypertension.

[93]  J. Penninger,et al.  Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. , 2010, American journal of physiology. Cell physiology.

[94]  K. Connelly,et al.  Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. , 2010, American journal of physiology. Heart and circulatory physiology.

[95]  J. Kopp,et al.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. , 2010, Journal of the American Society of Nephrology : JASN.

[96]  A. Sanz,et al.  Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. , 2009, American journal of physiology. Heart and circulatory physiology.

[97]  Vijay G Divakaran,et al.  Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure Overloading , 2009, Circulation. Heart failure.

[98]  F. Chen,et al.  Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling* , 2009, The Journal of Biological Chemistry.

[99]  R. Derynck,et al.  Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. , 2009, Developmental cell.

[100]  N. Frangogiannis,et al.  Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload , 2009, Histochemistry and Cell Biology.

[101]  H. Krum,et al.  Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy , 2009, Circulation. Heart failure.

[102]  G. Taffet,et al.  Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. , 2008, Journal of the American College of Cardiology.

[103]  K. Chatila,et al.  CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response1 , 2008, The Journal of Immunology.

[104]  S. Oparil,et al.  Atrial Natriuretic Peptide Inhibits Transforming Growth Factor β–Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts , 2008, Circulation research.

[105]  Ken-ichi Aihara,et al.  Pitavastatin, an HMG-CoA Reductase Inhibitor, Exerts eNOS-Independent Protective Actions Against Angiotensin II–Induced Cardiovascular Remodeling and Renal Insufficiency , 2008, Circulation research.

[106]  H. You,et al.  The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. , 2007, Carcinogenesis.

[107]  Guofeng Ren,et al.  Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling , 2007, Circulation.

[108]  R. A. Rahimi,et al.  TGF‐β signaling: A tale of two responses , 2007 .

[109]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[110]  Stephen C. Jones,et al.  Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. , 2007, American journal of physiology. Heart and circulatory physiology.

[111]  K. Miyazono,et al.  Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors* , 2007, Journal of Biological Chemistry.

[112]  Yunliang Chen,et al.  FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. , 2007, Molecular biology of the cell.

[113]  P. Dijke,et al.  Transforming Growth Factor-β Receptor Type I-dependent Fibrogenic Gene Program Is Mediated via Activation of Smad1 and ERK1/2 Pathways* , 2007, Journal of Biological Chemistry.

[114]  K. Fujiwara,et al.  ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.

[115]  T. Pawson,et al.  Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses , 2006, The Journal of Immunology.

[116]  H. Drexler,et al.  The Transforming Growth Factor-&bgr; Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury , 2006, Circulation research.

[117]  K. Berecek,et al.  Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. , 2006, Biochemical and biophysical research communications.

[118]  N. Xu,et al.  Targeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure , 2005, Circulation research.

[119]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[120]  M. Entman,et al.  Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts , 2005, Circulation.

[121]  S. Leivonen,et al.  Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. , 2005, The Journal of investigative dermatology.

[122]  K. Miyazono,et al.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. , 2005, Cytokine & growth factor reviews.

[123]  I. Kawase,et al.  Smad1 Protects Cardiomyocytes From Ischemia-Reperfusion Injury , 2005, Circulation.

[124]  KeikoYamauchi-Takihara,et al.  Smad1 Protects Cardiomyocytes From Ischemia-Reperfusion Injury , 2005 .

[125]  M. Goumans,et al.  Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.

[126]  T. Akiyama,et al.  Transcriptional regulation of the TGF-β pseudoreceptor BAMBI by TGF-β signaling , 2004 .

[127]  K. Miyazono,et al.  Roles for the MH2 Domain of Smad7 in the Specific Inhibition of Transforming Growth Factor-β Superfamily Signaling* , 2004, Journal of Biological Chemistry.

[128]  M. Entman,et al.  Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. , 2004, The American journal of pathology.

[129]  K. Luo.  Ski and SnoN: negative regulators of TGF-β signaling , 2004 .

[130]  H. Ihn,et al.  Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. , 2004, The Journal of clinical investigation.

[131]  K. Miyazono,et al.  Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. , 2003, Molecular biology of the cell.

[132]  Y. Shiratori,et al.  Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[133]  Harvey F Lodish,et al.  An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity , 2003, Oncogene.

[134]  Justin P. Annes,et al.  Making sense of latent TGFβ activation , 2003, Journal of Cell Science.

[135]  C. Zimmerman,et al.  Modulation of Smad2-mediated Signaling by Extracellular Signal-regulated Kinase* , 2002, The Journal of Biological Chemistry.

[136]  M. Arévalo,et al.  Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in Mice , 2002, Hypertension.

[137]  J. Cogan,et al.  Vascular Smooth Muscle α-Actin Gene Transcription during Myofibroblast Differentiation Requires Sp1/3 Protein Binding Proximal to the MCAT Enhancer* , 2002, The Journal of Biological Chemistry.

[138]  Yunliang Chen,et al.  Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. , 2002 .

[139]  Stephen C. Jones,et al.  Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.

[140]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[141]  M. Reiss,et al.  Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function. , 2002, The Journal of biological chemistry.

[142]  K. Miyazono,et al.  The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling , 2001, The Journal of cell biology.

[143]  I. Dixon,et al.  Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. , 2000, American journal of physiology. Heart and circulatory physiology.

[144]  K. Krieglstein,et al.  Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. , 2000, European journal of biochemistry.

[145]  J. Massagué,et al.  How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.

[146]  C. H. Conrad,et al.  Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice , 2000 .

[147]  S. Rosenkranz,et al.  Autocrine Regulation of TGF β Expression in Adult Cardiomyocytes , 1999 .

[148]  I. Dixon,et al.  Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. , 1999, Journal of molecular and cellular cardiology.

[149]  M. Lindsey,et al.  Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. , 1998, Circulation.

[150]  A. Geinoz,et al.  The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, The Journal of cell biology.

[151]  J. Massagué,et al.  SMADs: mediators and regulators of TGF-β signaling , 1998 .

[152]  J. Massagué,et al.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.

[153]  M. Daemen,et al.  A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart , 1997, Nature Medicine.

[154]  W A Hsueh,et al.  Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. , 1996, The Journal of clinical investigation.

[155]  P. Brauer,et al.  Latent transforming growth factor‐β is present in the extracellular matrix of embryonic hearts in situ , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[156]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.

[157]  K. Weber,et al.  Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.

[158]  N. Frangogiannis,et al.  The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[159]  N. Frangogiannis,et al.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. , 2016, Journal of molecular and cellular cardiology.

[160]  I. Sjaastad,et al.  Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload. , 2012, Cardiovascular research.

[161]  J. S. Janicki,et al.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling. , 2011, Cardiovascular research.

[162]  Yunliang Chen,et al.  Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts. , 2009, Arthritis and rheumatism.

[163]  R. Randall,et al.  Transforming Growth Factor (cid:2) -Induced Smad1/5 Phosphorylation in Epithelial Cells Is Mediated by Novel Receptor Complexes and Is Essential for Anchorage-Independent Growth (cid:1) † , 2008 .

[164]  辻江正徳.  TGF-β（transforming growth factor-β） , 2002 .

[165]  W. Gelbart,et al.  Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. , 1995, Genetics.

[166]  Expression of Proatherogenic Genes Primary Human Macrophages and Induces Proteins, Activates Smad1/5 Pathway in 1, but Not Bone Morphogenetic b TGF-Kzhyshkowska , 2022 .

[167]  N. Frangogiannis,et al.  RESEARCH ARTICLE Integrative Cardiovascular Physiology and Pathophysiology Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction , 2022 .